Effectiveness and Cost-Efficiency of Aquatic Exercise for Management of Osteoarthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00653497|
Recruitment Status : Completed
First Posted : April 7, 2008
Last Update Posted : April 7, 2008
The purpose of this study was to estimate the cost and outcomes of the Arthritis Foundation aquatic exercise classes.
- DESIGN. Randomized trial of 20-week aquatic classes.
- SUBJECTS AND METHODS. Recruited 249 adults from Washington State aged 55 to 75 with a doctor-confirmed diagnosis of osteoarthritis
- MEAURES. The Quality of Well-Being Scale (QWB), Current Health Desirability Rating (CHDR), Health Assessment Questionnaire(HAQ), Center for Epidemiologic Studies-Depression Scale (CES-D), Perceived Quality of Life Scale (PQOL)
|Condition or disease||Intervention/treatment||Phase|
|Osteoarthritis||Behavioral: Aquatic exercise||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||249 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Effectiveness and Cost-Efficiency of Aquatic Exercise for Management of Osteoarthritis|
|Study Start Date :||March 1997|
|Actual Primary Completion Date :||June 1998|
|Actual Study Completion Date :||June 1998|
Community-based aquatic exercise program (Arthritis Foundation Aquatics Program). Two classes per week, 45-60 minutes in duration.
Behavioral: Aquatic exercise
Arthritis Foundation Aquatics Program
No Intervention: 2
Usual care; abstention from initiation of new exercise programs. Invited to participate in Arthritis Foundation Aquatics Program after study completion.
- Quality of Well-Being Scale
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00653497
|Principal Investigator:||Donald L Patrick, PhD, MSPH||University of Washington|